T2N0M0(II期)喉鳞癌的生存结局
2年总生存81%(95%CI 59%-92%),疾病特异性生存91%(95%CI 69%-98%),无复发生存84%(95%CI 65%-93%)。结论认为II期喉癌生存结局欠佳,反映合并症、异时性原发肿瘤及晚期治疗效应而非局部区域控制不佳。
要点
- 12%手术、65%放疗、24%放化疗;59%肿瘤起源于声门。
- 5例持续/复发者中4例全喉切除补救,获100%局部区域控制。
核心结论
- II期喉癌生存结局欠佳,似乎反映合并症、异时性原发肿瘤倾向及晚期治疗效应,而非局部区域控制不佳。
研究设计与样本
- 病例系列(计划性数据收集),三级学术中心,2003-2014年头颈癌流行病学数据库查询。
主要发现
- 59%肿瘤起源于声门;12%接受手术、65%放疗、24%放化疗。
- 估计2年总生存81%(95%CI 59%-92%),疾病特异性生存91%(95%CI 69%-98%),无复发生存84%(95%CI 65%-93%)。
- 5例治疗后持续或复发患者中4例经全喉切除成功补救,获100%局部区域控制。
- 共11例死亡:2例疾病相关、2例异时性原发、3例治疗相关、4例其他/未知原因。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective Emerging data have demonstrated suboptimal outcomes among patients with stage II larynx cancer. Our objective is to report survival outcomes for T2N0M0 larynx cancer and to determine the cause-specific survival. Study Design Case series with planned data collection. Setting Tertiary academic center. Subjects Adults with T2N0M0 squamous cell carcinoma of the larynx treated with curative intent. Methods A head and neck cancer epidemiology database was queried for eligible subjects from 2003 to 2014. Data were extracted from the electronic medical record and research database, and survival analyses were performed. Results Thirty-four patients with previously untreated stage II larynx cancer were identified (median follow-up 48 months). Patients included 27 males and 7 females with a mean age of 59 years. The majority of tumors arose from the glottis (59%). Of the cohort, 12% were treated with surgery, 65% radiation therapy, and 24% chemoradiation therapy. The estimated 2-year overall survival was 81%, (95% confidence interval [CI], 59%-92%), disease-specific survival was 91% (95% CI, 69%-98%), and recurrence-free survival was 84% (95% CI, 65%-93%). Four of 5 patients with persistent or recurrent disease posttreatment were successfully salvaged with total laryngectomy with 100% locoregional control. There were 11 mortalities (2 disease related, 2 due to metachronous primaries, 3 treatment related, and 4 from other/unknown causes). Conclusion Stage II laryngeal cancer has suboptimal survival outcomes. This appears to be a reflection of medical comorbidities, propensity for metachronous primaries, and the sequelae of late treatment effects rather than poor locoregional control.
引用
- Gainor DL, Marchiano E, Bellile E, et al. Survival Outcomes in Patients with T2N0M0 (Stage II) Squamous Cell Carcinoma of the Larynx. Otolaryngol Head Neck Surg. 2017. PMID: 28608731. doi:10.1177/0194599817711374
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。